Accurately diagnose pharyngitis caused by Group A Streptococcus (GAS)
Annually, 616 million people have GAS pharyngitis, more than 18.1 million people develop severe GAS disease and more than 517,000 people die due to severe GAS disease1
Reduce overuse of antibiotics for the treatment of pharyngitis.
Based on recent literature shows 37% of children presenting with pharyngitis tested positive for GAS, however 56% of visits were associated with antibiotic prescriptions. Similarly, 18% of adults presented with pharyngitis caused by GAS, but 72% were treated with antibiotics.2
(1) Jonathan R Carapetis, Andrew C Steer et al. The global burden of group A streptococcal diseases. 2005 Nov. Available from https://pubmed.ncbi.nlm.nih.gov/16253886/ (2) Fleming-Dutra KE, et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016 May 3;315(17):1864-73.
The Solution
Cepheid's on-demand testing for Group A Strep test:
Produces results in as soon as 18 minutes*
Delivers careful selection of target gene
Eliminates the need to perform culture confirmation of negative results
Expedites treatment decisions
* For Positive samples only: otherwise, the test runtime is approximately 24 minutes.
The Impact
Support antimicrobial stewardship with accurate diagnosis of GAS and reduce the amount of patients inappropriately prescribed antibiotics.
Gain testing efficiencies and reduce costs by eliminating culture confirmation testing.3,#
Reduce the risk of GAS complications such as rheumatic fever and glomerulonephritis.
Improve patient satisfaction with quicker time to result and appropriate prescriptions.
(3) Workflow studies conducted by Cepheid Solutions demonstrate that a throat culture confirmation workup costs~ $9.13 per culture. (Average cost includes reagents, labor cost and time). Data on file. # Addtional follow-up testing by culture is required if the Xpert Xpress Strep A test result is negative and clinical symptoms persist, or there is an outbreak of acute rheumatic fever (ARF).
Related Products
Xpert SA Nasal Complete
Pre-surgical S. aureus and MRSA in about an hour
Learn more
Xpert Xpress CoV-2/Flu/RSV plus
Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses
Learn more
Xpert MTB/RIF
Accurate Detection of MTB and Rifampin Resistance Mutations
Learn more
Xpert Xpress CoV-2 plus
Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2